Utility of the methylated SEPT9 test for the early detection of colorectal cancer: a systematic review and meta-analysis of diagnostic test accuracy

BACKGROUND: Circulating tumour DNA from colorectal cancer (CRC) is a biomarker for early detection of the disease and therefore potentially useful for screening. One such biomarker is the methylated SEPT9 (mSEPT9) gene, which occurs during CRC tumourigenesis. This systematic review and meta-analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Hariharan, Rohit, Jenkins, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Colorectal Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039590/
https://www.ncbi.nlm.nih.gov/pubmed/32128229
http://dx.doi.org/10.1136/bmjgast-2019-000355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039590/
https://www.ncbi.nlm.nih.gov/pubmed/32128229
http://dx.doi.org/10.1136/bmjgast-2019-000355

Ejemplares similares